BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 38193535)

  • 21. High frequencies of Th1-type CD4(+) T cells specific to HTLV-1 Env and Tax proteins in patients with HTLV-1-associated myelopathy/tropical spastic paraparesis.
    Goon PK; Hanon E; Igakura T; Tanaka Y; Weber JN; Taylor GP; Bangham CR
    Blood; 2002 May; 99(9):3335-41. PubMed ID: 11964301
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mediators of central nervous system damage during the progression of human T-cell leukemia type I-associated myelopathy/tropical spastic paraparesis.
    Barmak K; Harhaj EW; Wigdahl B
    J Neurovirol; 2003 Oct; 9(5):522-9. PubMed ID: 13129766
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Role of Integrin Signaling Activation on the Development of Human T Cell Leukemia Virus-1 (HTLV-1)-Associated Myelopathy/Tropical Spastic Paraparesis: Its Relationship to HTLV-1-Infected CD4
    Nakamura T; Satoh K; Nakamura H; Fukushima N; Nishiura Y; Furuya T; Ichinose K
    AIDS Res Hum Retroviruses; 2018 Apr; 34(4):331-336. PubMed ID: 29400072
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Altered expression of degranulation-related genes in CD8+ T cells in human T lymphotropic virus type I infection.
    Malta TM; Silva IT; Pinheiro DG; Santos AR; Pinto MT; Panepucci RA; Takayanagui OM; Tanaka Y; Covas DT; Kashima S
    AIDS Res Hum Retroviruses; 2013 May; 29(5):826-36. PubMed ID: 23301858
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Flow cytometry evaluation of the T-cell receptor Vbeta repertoire among human T-cell lymphotropic virus type-1 (HTLV-1) infected individuals: effect of interferon alpha therapy in HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP).
    Saito M; Nose H; Usuku K; Sabouri AH; Matsuzaki T; Izumo S; Arimura K; Osame M
    J Neurol Sci; 2006 Jul; 246(1-2):37-43. PubMed ID: 16545396
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Low frequency of CD94/NKG2A+ T lymphocytes in patients with HTLV-1-associated myelopathy/tropical spastic paraparesis, but not in asymptomatic carriers.
    Saito M; Braud VM; Goon P; Hanon E; Taylor GP; Saito A; Eiraku N; Tanaka Y; Usuku K; Weber JN; Osame M; Bangham CR
    Blood; 2003 Jul; 102(2):577-84. PubMed ID: 12560226
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Multistability in a model for CTL response to HTLV-I infection and its implications to HAM/TSP development and prevention.
    Gómez-Acevedo H; Li MY; Jacobson S
    Bull Math Biol; 2010 Apr; 72(3):681-96. PubMed ID: 20041353
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Impaired function of human T-lymphotropic virus type 1 (HTLV-1)-specific CD8+ T cells in HTLV-1-associated neurologic disease.
    Sabouri AH; Usuku K; Hayashi D; Izumo S; Ohara Y; Osame M; Saito M
    Blood; 2008 Sep; 112(6):2411-20. PubMed ID: 18502825
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Enhanced T-Cell Maturation and Monocyte Aggregation Are Features of Cellular Inflammation in Human T-Lymphotropic Virus Type 1-Associated Myelopathy.
    Saeed Z; Rowan A; Greiller C; Taylor GP; Pollock KM
    Clin Infect Dis; 2020 Mar; 70(7):1326-1335. PubMed ID: 31063543
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The IL-18, IL-12, and IFN-γ expression in HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP) patients, HTLV-1 carriers, and healthy subjects.
    Bidkhori HR; Hedayati-Moghaddam MR; Mosavat A; Valizadeh N; Tadayon M; Ahmadi Ghezeldasht S; Rafatpanah H; Rezaee SA
    J Neurovirol; 2020 Jun; 26(3):338-346. PubMed ID: 32270468
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Expression of TSLC1 in patients with HAM/TSP.
    Takenouchi N; Tanaka M; Sato T; Yao J; Fujisawa JI; Izumo S; Kubota R; Matsuura E
    J Neurovirol; 2020 Jun; 26(3):404-414. PubMed ID: 32285300
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Autonomous proliferation of HTLV-CD4+ T cell clones derived from human T cell leukemia virus type I (HTLV-I)-associated myelopathy patients.
    Miyano-Kurosaki N; Kira J; Barnor JS; Maeda N; Misawa N; Kawano Y; Tanaka Y; Yamamoto N; Koyanagi Y
    Microbiol Immunol; 2007; 51(2):235-42. PubMed ID: 17310092
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Correlation of human T-cell lymphotropic virus type 1 (HTLV-1) mRNA with proviral DNA load, virus-specific CD8(+) T cells, and disease severity in HTLV-1-associated myelopathy (HAM/TSP).
    Yamano Y; Nagai M; Brennan M; Mora CA; Soldan SS; Tomaru U; Takenouchi N; Izumo S; Osame M; Jacobson S
    Blood; 2002 Jan; 99(1):88-94. PubMed ID: 11756157
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Human T lymphotropic virus type 1 (HTLV-1) proviral load induces activation of T-lymphocytes in asymptomatic carriers.
    Coutinho R; Grassi MF; Korngold AB; Olavarria VN; Galvão-Castro B; Mascarenhas RE
    BMC Infect Dis; 2014 Aug; 14():453. PubMed ID: 25148903
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tropical spastic paraparesis and HTLV-1 associated myelopathy: clinical, epidemiological, virological and therapeutic aspects.
    Gessain A; Mahieux R
    Rev Neurol (Paris); 2012 Mar; 168(3):257-69. PubMed ID: 22405461
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Differential effect of TGF-beta 1 on the in vitro activation of HTLV-I and the proliferative response of CD8+ T lymphocytes in patients with HTLV-I-associated myelopathy (HAM/TSP).
    Nagai M; Ijichi S; Hall WW; Osame M
    Clin Immunol Immunopathol; 1995 Dec; 77(3):324-31. PubMed ID: 7586743
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Positive feedback loop via astrocytes causes chronic inflammation in virus-associated myelopathy.
    Ando H; Sato T; Tomaru U; Yoshida M; Utsunomiya A; Yamauchi J; Araya N; Yagishita N; Coler-Reilly A; Shimizu Y; Yudoh K; Hasegawa Y; Nishioka K; Nakajima T; Jacobson S; Yamano Y
    Brain; 2013 Sep; 136(Pt 9):2876-87. PubMed ID: 23892452
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Following the Clues: Usefulness of Biomarkers of Neuroinflammation and Neurodegeneration in the Investigation of HTLV-1-Associated Myelopathy Progression.
    Souza FDS; Freitas NL; Gomes YCP; Torres RC; Echevarria-Lima J; da Silva-Filho IL; Leite ACCB; de Lima MASD; da Silva MTT; Araújo AQC; Espíndola OM
    Front Immunol; 2021; 12():737941. PubMed ID: 34764955
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Levels of serum chemokines discriminate clinical myelopathy associated with human T lymphotropic virus type 1 (HTLV-1)/tropical spastic paraparesis (HAM/TSP) disease from HTLV-1 carrier state.
    Guerreiro JB; Santos SB; Morgan DJ; Porto AF; Muniz AL; Ho JL; Teixeira AL; Teixeira MM; Carvalho EM
    Clin Exp Immunol; 2006 Aug; 145(2):296-301. PubMed ID: 16879249
    [TBL] [Abstract][Full Text] [Related]  

  • 40. CD49d Is Upregulated in Circulating T Lymphocytes from HTLV-1-Infected Patients.
    Janahú LTA; Da Costa CA; Vallinoto ACR; Santana BB; Ribeiro-Lima J; Santos-Oliveira JR; Chometon TQ; Bertho AL; Savino W; Da-Cruz AM; Gomes-Silva A
    Neuroimmunomodulation; 2020; 27(2):113-122. PubMed ID: 32756050
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.